Have a personal or library account? Click to login
Impaired booster-induced SARS-CoV-2 antibody responses in rituximab-treated B-cell lymphoma patients despite peripheral B-Cell Recovery Cover

Impaired booster-induced SARS-CoV-2 antibody responses in rituximab-treated B-cell lymphoma patients despite peripheral B-Cell Recovery

Radiology and Oncology
Volume 60 (2026): Issue 1 (March 2026)
By: Tomaz Jurca,  Lucka Boltezar,  Miha Orazem,  Kristina Fujs Komlos,  Katka Pohar,  Sara Jevnikar,  Mario Poljak,  Denis Mlakar Mastnak,  Nada Rotovnik Kozjek,  Bor Vratanar,  Janja Ocvirk and  Alojz Ihan  
Open Access
|Mar 2026

Authors

Tomaz Jurca

Institute of Oncology Ljubljana, Ljubljana, Slovenia
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Lucka Boltezar

Institute of Oncology Ljubljana, Ljubljana, Slovenia
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Miha Orazem

Institute of Oncology Ljubljana, Ljubljana, Slovenia
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Kristina Fujs Komlos

Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Katka Pohar

Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Sara Jevnikar

Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Mario Poljak

Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Denis Mlakar Mastnak

Institute of Oncology Ljubljana, Ljubljana, Slovenia

Nada Rotovnik Kozjek

Institute of Oncology Ljubljana, Ljubljana, Slovenia
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Bor Vratanar

Institute for Biostatistics and Medical Informatics, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Janja Ocvirk

jocvirk@onko-i.si

Institute of Oncology Ljubljana, Ljubljana, Slovenia
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Faculty of Health Sciences, University of Primorska, Izola, Slovenia

Alojz Ihan

Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
DOI: https://doi.org/10.2478/raon-2026-0014 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 76 - 85
Submitted on: Feb 16, 2026
|
Accepted on: Feb 24, 2026
|
Published on: Mar 24, 2026
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
lymphoma,
B-cell,
rituximab,
COVID-19 vaccines,
humoral immunity,
antibodies,
viral
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2026 Tomaz Jurca, Lucka Boltezar, Miha Orazem, Kristina Fujs Komlos, Katka Pohar, Sara Jevnikar, Mario Poljak, Denis Mlakar Mastnak, Nada Rotovnik Kozjek, Bor Vratanar, Janja Ocvirk, Alojz Ihan, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 60 (2026): Issue 1 (March 2026)Next article